Literature DB >> 11667650

Competing Rearrangements of Ammonium Ylides: A Quantum Theoretical Study.

George L. Heard1, Brian F. Yates.   

Abstract

The competition between the Stevens [1,2] and Sommelet-Hauser [2,3] rearrangements for a prototype ylide, N-methyl-3-propenylammonium methylide, has been investigated using ab initio and semiempirical molecular orbital methods. The activation energies for the two processes are remarkably close, separated by only 2 kJ mol(-)(1) at ROMP/6-311+G(d,p). Increasing the size of the basis set leads to a relative stabilization of the Sommelet-Hauser transition geometry, while higher levels of electron correlation (such as CCSD(T)) favor the Stevens rearrangement. Incorporation of solvent effects via the SCRF polarizable continuum model leads to a lowering of the energy barrier of the concerted [2,3] rearrangement, but has little effect on the dissociative [1,2] pathway. The activation energies of both pathways have been calculated for ylides bearing substituents on the ammonium nitrogen and the double bond. Substituents at nitrogen lead to an ylide which is sterically unstable and hence a preference for the dissociative [1,2] rearrangement. Electron-withdrawing substituents on the double bond show a preference for the [2,3] rearrangement, while mildly electron-donating alkyl substituents have very little effect on activation energies.

Entities:  

Year:  1996        PMID: 11667650     DOI: 10.1021/jo952227w

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Stereoselective [2,3]-sigmatropic rearrangements of unstabilized nitrogen ylides.

Authors:  Robert E Gawley; Kwangyul Moon
Journal:  Org Lett       Date:  2007-07-12       Impact factor: 6.005

2.  Dynamics and a unified understanding of competitive [2,3]- and [1,2]-sigmatropic rearrangements based on a study of ammonium ylides.

Authors:  Bibaswan Biswas; Sean C Collins; Daniel A Singleton
Journal:  J Am Chem Soc       Date:  2014-02-28       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.